|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 523.66 USD | -0.20% |
|
-1.02% | +7.57% |
| Market Cap | 22.27B 19.57B 18.27B 16.76B 31.38B 2,133B 32.16B 217B 84.71B 1,056B 83.62B 81.8B 3,649B | P/E 2026 * |
19.5x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 19.63B 17.25B 16.1B 14.77B 27.65B 1,880B 28.34B 191B 74.65B 930B 73.69B 72.09B 3,216B | EV / Sales 2026 * |
6.06x | EV / Sales 2027 * | 5x |
| Free-Float |
53.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: United Therapeutics Corporation
| 1 day | +0.30% | ||
| 1 week | -1.02% | ||
| Current month | -3.26% | ||
| 1 month | -3.26% | ||
| 3 months | -8.26% | ||
| 6 months | +11.64% | ||
| Current year | +7.57% |
| 1 week | 517.61 |  | 537.76 |
| 1 month | 517.61 | | 563.7 |
| Current year | 455.63 | | 609.35 |
| 1 year | 272.12 | | 609.35 |
| 3 years | 208.62 | | 609.35 |
| 5 years | 158.38 | | 609.35 |
| 10 years | 74.31 | | 609.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 26/06/1996 | |
| President | 54 | 26/06/2016 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 13/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 01/01/2002 |
| Chairman | 71 | 26/06/1996 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 01/01/2002 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/07/26 | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% | ||
| 27/07/26 | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% | ||
| 24/07/26 | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.20% | -1.02% | +85.90% | +115.95% | 22.27B | |
| -4.23% | -1.90% | +53.06% | +155.94% | 1,079B | |
| -3.83% | -1.47% | +52.73% | +52.49% | 640B | |
| -3.32% | -0.47% | +35.08% | +70.96% | 465B | |
| -2.20% | +1.00% | +35.98% | +30.45% | 353B | |
| -2.30% | -0.61% | +33.53% | +39.32% | 301B | |
| -2.86% | +0.69% | +11.11% | +14.21% | 271B | |
| -2.26% | +3.22% | +1.72% | -39.46% | 228B | |
| -2.25% | +2.12% | +25.89% | +62.02% | 209B | |
| -3.24% | -1.31% | +12.53% | +69.62% | 165B | |
| Average | -2.44% | +2.93% | +34.75% | +57.15% | 373.19B | |
| Weighted average by Cap. | -3.09% | +3.75% | +38.28% | +74.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.24B 2.84B 2.65B 2.44B 4.56B 310B 4.67B 31.47B 12.31B 153B 12.15B 11.89B 530B | 3.68B 3.23B 3.02B 2.77B 5.19B 353B 5.31B 35.79B 14B 174B 13.82B 13.52B 603B |
| Net income | 1.25B 1.09B 1.02B 938M 1.76B 119B 1.8B 12.12B 4.74B 59.05B 4.68B 4.58B 204B | 1.47B 1.3B 1.21B 1.11B 2.08B 141B 2.13B 14.34B 5.61B 69.88B 5.54B 5.42B 242B |
| Net Debt | -2.65B -2.32B -2.17B -1.99B -3.73B -253B -3.82B -25.73B -10.06B -125B -9.93B -9.72B -434B | -3.87B -3.4B -3.17B -2.91B -5.45B -371B -5.59B -37.63B -14.72B -183B -14.53B -14.21B -634B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | $525.12 | +0.08% | 37,297 |
| 29/07/26 | $524.70 | +0.20% | 560,581 |
| 28/07/26 | $523.63 | -0.82% | 446,331 |
| 27/07/26 | $527.94 | -0.10% | 431,349 |
| 24/07/26 | $528.47 | -0.20% | 313,248 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
